Nearly 150 primary care clinics serving older Americans are about to get a new majority owner. Humana said Tuesday that BlackRock, the giant investment manager, will replace private equity firm Welsh, Carson, Anderson & Stowe (WCAS) as its partner in the venture that owns the clinics, in a deal valued at about $2.8 billion.
The handoff shifts a major part of senior health care from one Wall Street owner to another. BlackRock will acquire the majority stake WCAS held. Humana’s CenterWell division will keep a minority stake and continue to manage and operate every clinic in the venture.
What the Deal Does
Humana described the arrangement in financial terms. The company said it will provide growth capital, lower Humana’s cost of capital and significantly reduce liabilities on its balance sheet. The announcement didn’t say what changes, if any, patients or clinic staff should expect.
Humana also said the transaction isn’t expected to have a material impact on its 2026 adjusted earnings guidance. The deal is expected to close in the fourth quarter of 2026, subject to regulatory approvals. Regulators therefore have a role before ownership formally changes hands.
An Option on the Clinics, and a Clock
The deal structure points to what may come next. Starting in 2028, CenterWell will have the option to buy clinics from the joint venture. If it hasn’t acquired all of them by the end of 2033, BlackRock can exit through a sale process, though CenterWell would have the right to submit the first offer.
The future of these clinics could eventually hinge on a sale process driven by an investor’s exit timeline, rather than the needs of the communities they serve.
Evercore ISI analyst Elizabeth Anderson offered a pointed read on the numbers. “The $2.8 billion represents the value of WCAS’s stake rather than announced proceeds to HUM,” she said. “The main benefit of the transition is that it grants HUM more time to further develop the portfolio of clinics (and raise profitability) and further delay the date they have to exercise their option,” Anderson added.
Put another way, the deal gives Humana time to raise clinic profitability before it has to buy the clinics back.
A Second Deal With the Same Partner
This is Humana’s second strategic transaction with BlackRock this year. Earlier, the companies agreed to divest Humana’s minority stake in Gentiva, a provider of hospice and palliative care services, to an investor consortium that includes BlackRock. Hospice and palliative care and primary care for seniors serve people at vulnerable moments in life, and both are now tied to the same investment manager.
The basic facts still leave plenty unanswered. Humana hasn’t said how patient care, staffing or clinic access might change. The company’s stated priorities are capital costs and balance-sheet liabilities.
Why This Matters:
Senior primary care isn’t an ordinary financial asset. Nearly 150 clinics serving older Americans are changing hands between institutional investors, under terms centered on capital costs, liabilities and exit timelines. Patients aren’t parties to these negotiations. With a purchase option opening in 2028 and a possible sale process after 2033, the clinics’ long-term ownership remains unsettled. Regulatory review before the fourth-quarter close is the main public checkpoint. Advocates for older patients and policymakers have reason to ask what protections apply to care when ownership is treated as a tradable stake, and whether the stated aim of raising clinic profitability fits comfortably alongside the needs of seniors who depend on these clinics.